ANAB vs NXPI · rev $234.6M vs P/E 29, rev $12.27B
AnaptysBio Inc (ANAB) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. ANAB currently screens at market cap $1.62B.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
ANAB currently screens at market cap $1.62B. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the ANAB and NXPI stock pages for the full models.
Not investment advice.